Clinical Trial: A Preliminary Study of an AI Model Based on Multimodal MRI for Predicting Response to Neoadjuvant Chemoradiotherapy and Risk of Radiation-Induced Enteritis in Rectal Cancer, and Their Association with the Tumor Immune Microenvironment. (China)

China, Oct. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Preliminary Study of an AI Model Based on Multimodal MRI for Predicting Response to Neoadjuvant Chemoradiotherapy and Risk of Radiation-Induced Enteritis in Rectal Cancer, and Their Association with the Tumor Immune Microenvironment.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135475

Registration Time: 2026/10/30

Type: Observational study

Primary Sponsor: Affiliated Hospital of Jiangnan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=310816

Published by HT Digital Content Services with permission from Health Daily Digest....